Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study-Reference-Cited by-同舟云学术

Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study

Published:2014-03 Issue:3 Volume:132 Page:585-592
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fleming Gini F.,Filiaci Virginia L.,Marzullo Brandon,Zaino Richard J.,Davidson Susan A.,Pearl Michael,Makker Vicky^ORCID,Burke James J.,Zweizig Susan L.,Van Le Linda,Hanjani Parviz,Downey Gordon,Walker Joan L.,Reyes Henry D.,Leslie Kimberly K.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose–response study by the Gynecologic Oncology Group;Thigpen;J Clin Oncol,1999

2. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study;Fiorica;Gynecol Oncol,2004

3. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study;Singh;Gynecol Oncol,2007

4. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study;Fleming;J Clin Oncol,2004

5. Molecular targets and targeted therapeutics in endometrial cancer;Weigelt;Curr Opin Oncol,2012

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis;Frontiers in Oncology;2024-05-03

2. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer;Cancer Treatment Reviews;2024-05

3. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options;Reproductive Sciences;2024-04-24

4. Clinical Characteristics and Prognostic Factors of Endometrial Cancer Patients With Liver Metastasis: A Surveillance, Epidemiology, and End Results Database (SEER)-Based Study of 1,034 Women;Cureus;2024-02-21

5. Complete radiological response when using pembrolizumab in the mono mode in the 2nd-line drug therapy of MSI-h / dMMR-positive advanced endometrial cancer. A clinical case;Surgery and Oncology;2023-12-21